Archives: Team

  • Christian LaPointe, Ph.D.

    Christian LaPointe, Ph.D.

    General Counsel Christian LaPointe, Ph.D. has served as Quantum-Si’s General Counsel since November 2020. Prior to joining Quantum-Si, Dr. LaPointe served as General Counsel at ArcherDX, Inc., a genomics company, from January 2015 to August 2019, and as Deputy General Counsel at ArcherDX from August 2019 to October 2020. Dr. LaPointe also served as General […]

  • Jeff Keyes

    Jeff Keyes

    Chief Financial Officer Mr. Keyes brings over 25 years of experience in senior financial positions providing financial leadership for emerging and evolving public and private companies. Previously, he served as the Chief Financial Officer of Spinal Elements, Inc., a private equity backed medical device company.  Prior to Spinal Elements, Mr. Keyes was the Chief Financial […]

  • Todd Rearick

    Todd Rearick

    Chief Technology Officer Todd Rearick has served as Quantum-Si’s Chief Technology Officer since January 2019. Prior to that Mr. Rearick served as Chief Technology Officer at Hyperfine Research from January 2018 to January 2019, and as Systems Engineer from June 2014 to January 2018. Prior to that Mr. Rearick was an Engineering Fellow at Life […]

  • Michael P. McKenna, Ph.D.

    Michael P. McKenna, Ph.D.

    Executive Vice President, Product Development and Operations Michael P. McKenna, Ph.D. has served as Quantum-Si’s Executive Vice President, Product Development and Operations since May 2022, and as Quantum-Si’s President and Chief Operating Officer since December 2014 to May 2022.Prior to joining Quantum-Si, Dr. McKenna served as Vice President, R&D at Life Technologies Corporation, a global […]

  • Grace Johnston, Ph.D.

    Grace Johnston, Ph.D.

    Chief Commercial Officer Grace Johnston has served as our Chief Commercial Officer since December 2022. She previously served as Chief Commercial Officer at Fortis Life Sciences from September 2020 until December 2022, where she was accountable for organic revenue contribution, annual growth targets, commercial go-to-market strategy, sales and marketing, as well as overall customer experience. […]

  • Patrick Schneider, Ph.D.

    Patrick Schneider, Ph.D.

    President and Chief Operating Officer Dr. Schneider has served in a number of roles at MilliporeSigma, including its predecessor entities (the life science business of Merck KGaA, Darmstadt, Germany), most recently as Senior Vice President, Strategy, Business Development and Innovation, and Chair of the Life Science Innovation Board from 2016 until April 2022, where he […]

  • Jeff Hawkins

    Jeff Hawkins

    Chief Executive Officer Mr. Hawkins brings over 20 years of experience at the world’s leading life science and diagnostics companies as an accomplished business leader and inventor. Prior to Quantum-Si, he was President and Chief Executive Officer of Truvian Sciences, Inc. where he led the evolution of the company’s benchtop blood testing system from a […]